Predicted to enable antiporter activity. Predicted to be located in membrane. Predicted to be integral component of membrane. Predicted to be active in Golgi apparatus. Is expressed in several structures, including cranial ganglion; craniocervical region bone; incisor; inner ear; and thoracic segment skeleton. Orthologous to human SLC35E1 (solute carrier family 35 member E1). [provided by Alliance of Genome Resources, Apr 2022]